RECALL on SYMJEPI® epinephrine autoinjectors

Adamis Pharmaceuticals Corporation is voluntarily recalling certain lots of SYMJEPI (epinephrine) Injection 0.15 mg (0.15 mg/0.3 mL) and 0.3 mg (0.3 mg/0.3 mL) Pre-Filled Single-Dose Syringes to the consumer level.
The voluntary recall was issued after two customer complaints were made on three syringes, regarding difficulty dispensing the product.
The batches listed in the table below are being recalled due to the potential clogging of the needle preventing the dispensing of epinephrine. The products are packaged in 2-count Pre-Filled Single-Dose Syringes per carton and were distributed nationwide in the United States and directly to customers and/or medical facilities.
Product Strength NDC Lot Expiration
SYMJEPI (epinephrine) Injection 0.15 mg/0.3 mL 78670-131-02 21101Y 11/30/2022
0.3 mg/0.3 mL 78670-130-02 21041W 8/31/2022
21081W 11/30/2022
21102W 2/28/2023